Perspective Therapeutics (CATX) announced that its Board of Directors has appointed Maya Martinez-Davis as an independent director to the Company’s Board of Directors, effective today. Martinez-Davis currently serves as President of GSK‘s (GSK) U.S. Commercial business, a position she has held since September 2019.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CATX:
- Perspective Therapeutics Updates on Radiopharmaceutical Advancements
- Promising Clinical Pipeline and Strategic Investments Justify Buy Rating for Perspective Therapeutics
- Perspective Therapeutics Reports Q2 2025 Progress and Financials
- Positive Outlook for Perspective Therapeutics: Buy Rating Driven by Promising Clinical Developments and Strategic Progress
- Perspective Therapeutics Reports Promising Study Results at ASCO